Application Nr Approved Date Route Status External Links
NDA022571 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cuvposa Is Indicated To Reduce Chronic Severe Drooling In Patients Aged 3 To 16 Years With Neurologic Conditions Associated With Problem Drooling (E.g., Cerebral Palsy). Cuvposa Is An Anticholinergic Indicated To Reduce Chronic Severe Drooling In Patients Aged 3-16 Years With Neurologic Conditions Associated With Problem Drooling (E.g., Cerebral Palsy). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Glycopyrrolate GLYCOPYRROLATE ZINC968301

Comments